Clinical evidence from protein profiling in the eye and cord blood serum also identified them as potential biomarkers for ROP progression, as they are reversely associated with IGF-1 levels (Hellgren et al., 2018; Lyu et al., 2018; Park et al., 2019). The gene discussed is IGF1; the disease is retinopathy of prematurity.